<DOC>
	<DOCNO>NCT00988988</DOCNO>
	<brief_summary>Participants ask study multiple sclerosis , currently treat glatiramer acetate ( GA , CopaxoneÂ® ) injection redness , pain , swell , itch lump injection site . The purpose study determine use ethyl-a-guanida-methyl ethanoate ( AGEE ) decrease histamine response measure redness , swell , itch response follow subcutaneous injection glatiramer acetate ( GA ) treatment Multiple Sclerosis ( MS ) .</brief_summary>
	<brief_title>The Effects Ethyl-Alpha-Guanido-Methyl Ethanoate Skin Reactions From Glatiramer Acetate Injections</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>Able give inform consent Between age 1965 Laboratory support diagnosis multiple sclerosis Currently treat injectable GA , experience wheal flare injection Unable give inform consent Treated therapy Multiple Sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>AGEE</keyword>
	<keyword>histamine response</keyword>
</DOC>